Stage IV Rectal Cancer
Showing 1 - 25 of >10,000
Quality of Life and Utilities Following Surgical Treatment of
Recruiting
- Rectal Adenocarcinoma
- +13 more
- Quality-of-Life Assessment
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Terminated
- Metastatic Colon Adenocarcinoma
- +27 more
- Binimetinib
- +3 more
-
San Francisco, California
- +1 more
Jan 5, 2023
Rectal Adenocarcinoma, Recurrent Rectal Carcinoma, Stage IV Rectal Cancer AJCC v7 Trial in Scottsdale, Rochester (other,
Completed
- Rectal Adenocarcinoma
- +4 more
- Quality-of-Life Assessment
- +2 more
-
Scottsdale, Arizona
- +1 more
Jan 3, 2023
Advanced Colon Adenocarcinoma, Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma Trial in Duarte
Active, not recruiting
- Advanced Colon Adenocarcinoma
- +24 more
- Ipilimumab
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 22, 2022
Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma Trial in United States (Laboratory
Active, not recruiting
- Metastatic Colon Carcinoma
- +24 more
- Laboratory Biomarker Analysis
- +2 more
-
Corona, California
- +7 more
Oct 26, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston (CXCR1/2
Recruiting
- Metastatic Colon Adenocarcinoma
- +20 more
- CXCR1/2 Inhibitor SX-682
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 17, 2022
Rectal Cancer Stage III, Rectal Cancer Stage IV Trial in Beijing (procedure, drug, device, diagnostic test)
Not yet recruiting
- Rectal Cancer Stage III
- Rectal Cancer Stage IV
- Sentinel lymph node biopsy
- +5 more
-
Beijing, Beijing, ChinaNational Cancer Center
Apr 26, 2023
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston
Active, not recruiting
- Colon Adenocarcinoma
- +10 more
- Anti-PD-L1/TGFbetaRII Fusion Protein M7824
-
Houston, TexasM D Anderson Cancer Center
Jan 12, 2022
Metastatic or Unresectable Colon or Rectal Cancer forCOLOMATE
Recruiting
- Metastatic Colon Adenocarcinoma
- +19 more
- Genetic Testing
-
Scottsdale, Arizona
- +17 more
Mar 2, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston
Recruiting
- Metastatic Colon Adenocarcinoma
- +30 more
- Abemaciclib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 24, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,
Not yet recruiting
- Metastatic Colon Adenocarcinoma
- +5 more
- Trastuzumab
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 31, 2023
Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma
Active, not recruiting
- Recurrent Malignant Solid Neoplasm
- +15 more
- Canady Helios Cold Plasma Scalpel
-
Washington, District of ColumbiaCanady Surgical Group PC
Jul 16, 2021
Advanced Colorectal Carcinoma, Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in United States
Recruiting
- Advanced Colorectal Carcinoma
- +26 more
- Irinotecan
- +2 more
-
Tampa, Florida
- +3 more
Jun 22, 2022
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8, Clinical
Recruiting
- Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
- +44 more
- Best Practice
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 3, 2021
Comprehensive Gene Sequencing in Guiding Treatment
Completed
- Recurrent Breast Cancer
- +7 more
- cytology specimen collection procedure
- laboratory biomarker analysis
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 21, 2021
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Not yet recruiting
- Metastatic Colon Adenocarcinoma
- +6 more
- Balstilimab
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 17, 2022
Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)
Completed
- Adult Solid Tumor
- +38 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Feb 18, 2021
Improve Organ Preserving Strategies in Rectal Cancer
Recruiting
- Rectal Adenocarcinoma
- +8 more
- Biopsy
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 30, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Colorectal Carcinoma Trial in Rochester
Recruiting
- Metastatic Colon Adenocarcinoma
- +10 more
- Colorectal Cancer Peptide Vaccine PolyPEPI1018
- Trifluridine and Tipiracil Hydrochloride
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 10, 2022
Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New
Recruiting
- Locally Advanced Rectal Carcinoma
- +2 more
- Capecitabine
- +9 more
-
Gainesville, Florida
- +1 more
Jan 4, 2023
Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8 Trial in United States
Recruiting
- Metastatic Colon Adenocarcinoma
- +7 more
- Cetuximab
- +2 more
-
Bloomington, Illinois
- +70 more
Aug 6, 2022
Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles
Active, not recruiting
- Mucinous Adenocarcinoma of the Rectum
- +7 more
- bevacizumab
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 5, 2022